$ 10.72
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Drugs Made In America Acquisition Corp. operates as a special purpose acquisition company (SPAC). Its primary objective is to achieve a business combination, which may involve a merger, an asset acquisition, a share exchange, or a corporate restructuring, with one or more existing enterprises. The firm was established on May 23, 2024, and maintains its principal office in Fort Lauderdale, Florida.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E.
Data is available to registered users only